A Comparison of Active Surveillance Programs Including a Spontaneous Reporting Model for Phamacovigilance of Adverse Drug Events in a Hospital |
Yun, Il Seon
(Severance Hospital Regional Pharmacovigilance Center)
Koo, Myung Jin (Severance Hospital Regional Pharmacovigilance Center) Park, Eun Hye (Severance Hospital Regional Pharmacovigilance Center) Kim, Sung-Eun (Severance Hospital Regional Pharmacovigilance Center) Lee, Jae-Hyun (Severance Hospital Regional Pharmacovigilance Center) Park, Jung-Won (Severance Hospital Regional Pharmacovigilance Center) Hong, Chein-Soo (Severance Hospital Regional Pharmacovigilance Center) |
1 | Forster AJ, Halil RB, Tierney MG. Pharmacist surveillance of adverse drug events. Am J Health Syst Pharm 2004;61:1466-1472. |
2 | Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med 1991;324:377-384. DOI ScienceOn |
3 | Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 2000;38:261-271. DOI ScienceOn |
4 | Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-306. DOI ScienceOn |
5 | Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2001;58:1126-1132. |
6 | Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention: ADE Prevention Study Group. JAMA 1995;274:29-34. DOI ScienceOn |
7 | Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005;165:1111-1116. DOI ScienceOn |
8 | Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-311. DOI ScienceOn |
9 | Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events: ADE Prevention Study Group. JAMA 1995;274:35-43. DOI ScienceOn |
10 | Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. JAMA 1998;280:1317-1320. DOI ScienceOn |
11 | Weaver J, Willy M, Avigan M. Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. AAPS J 2008;10:35-41. DOI |
12 | Zancan A, Locatelli C, Ramella F, et al. A new model of pharmacovigilance? A pilot study. Biomed Pharmacother 2009;63:451-455. DOI ScienceOn |
13 | Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993;8:289-294. DOI ScienceOn |
14 | Keith MR, Bellanger-McCleery RA, Fuchs JE Jr. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm 1989;46:1809-1812. |
15 | Faich GA. National adverse drug reaction reporting: 1984-1989. Arch Intern Med 1991;151:1645-1647. DOI ScienceOn |
16 | Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998;5:305-314. DOI ScienceOn |
17 | Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care 2000;12:69-76. DOI ScienceOn |
18 | Hwang SH, Lee S, Koo HK, Kim Y. Evaluation of a computer-based adverse-drug-event monitor. Am J Health Syst Pharm 2008;65:2265-2272. DOI ScienceOn |
19 | Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm 1988;45:1534-1539. |
20 | Rogers AS, Israel E, Smith CR, et al. Physician knowledge, attitudes, and behavior related to reporting adverse drug events. Arch Intern Med 1988;148:1596-1600. DOI ScienceOn |
21 | Schiff GD. Using a computerized discharge summary data base check box for adverse drug reaction monitoring. QRB Qual Rev Bull 1990;16:149-155. DOI |
22 | Cullen DJ, Bates DW, Small SD, Cooper JB, Nemeskal AR, Leape LL. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21:541-548. |
23 | The Uppsala Monitoring Centre. The WHO-ART Adverse Reaction Terminology. Uppsala: The Uppsala Monitoring Centre, 1992. |
24 | Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-1259. DOI ScienceOn |
25 | Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997;52:388-393. DOI ScienceOn |
26 | Vallano A, Cereza G, Pedros C, et al. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol 2005;60:653-658. DOI ScienceOn |
27 | Miwa LJ, Randall RJ. Adverse drug reaction program using pharmacist and nurse monitors. Hosp Formul 1986;21:1140-1146. |
28 | Marcondes RA. Dental care of the cardiac patient. Ars Curandi Odontol 1976;2:3-8. |
29 | Choi JH, Shin YS, Suh CH, Nahm DH, Park HS. The frequency of adverse drug reactions in a tertiary care hostpital in Korea. Korean J Med 2004;67:290-296. |
30 | Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991;266:2847-2851. DOI ScienceOn |
31 | Kunac DL, Kennedy J, Austin N, Reith D. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs 2009;11:153-160. DOI ScienceOn |
32 | Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA 2001;285:2114-2120. DOI ScienceOn |
33 | Holdsworth MT, Fichtl RE, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients. Arch Pediatr Adolesc Med 2003;157:60-65. DOI ScienceOn |